Abstract
55 A phase I study of SB-715992, a novel kinesin spindle protein (KSP) inhibitor: pharmacokinetic (PK)/pharmacodynamic (PD) modeling of absolute neutrophil counts (ANC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have